Skip to main content

Table 1 Patients’ characteristics

From: Exploring MR regression patterns in rectal cancer during neoadjuvant radiochemotherapy with daily T2- and diffusion-weighted MRI

Characteristics

Value

Percent

Age (y)

 - Median

63.5

 

 - Range

51–72

 

Gender

 -Female

5

62.5

 -Male

3

37.5

Clinical stage before treatment (n)

 -cT2 N1

1

12.5

 -cT3 N0–2

7

87.5

Pathological stage (n)

 -ypT0 N0 (pCR)

4

50.0

 -ypT2 N0–1

2

25.0

 -ypT3 N0–2

2

25.0

Dworak tumor regression grade (TRG)

 -Dominant tumor mass with obvious fibrosis (TRG 1 = minimal regression)

2

25.0

 -Dominantly fibrotic changes with few tumor cells or groups (TRG 2 = moderate regression)

1

12.5

 -Very few tumor cells (TRG 3 = near pCR)

1

12.5

 -No tumor cells (TRG 4 = pCR)

4

50.0

Initial tumor volume (ml)

 -Median

33.5

 

 -Range

14–95

 

Total treatment time (d)

 -Median

40

 

 -Range

37–43

 
  1. Abbreviations: y years, n number, pCR pathological complete response, TRG tumor regression grade, ml milliliters, d days